FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007445647> ?p ?o ?g. }

• W2007445647 endingPage "589" @default.
• W2007445647 startingPage "582" @default.
• W2007445647 abstract "Repetitive behaviors are a core symptom domain in autism that has been linked to alterations in the serotonin system. While the selective serotonin-receptive inhibitor fluvoxamine has been shown to be effective in adults with autism, as yet no published placebo controlled trials with these agents document safety and efficacy in children with autism. This study examines the selective serotonin reuptake inhibitor liquid fluoxetine in the treatment of repetitive behaviors in childhood and adolescent autism spectrum disorders (ASDs). In total, 45 child or adolescent patients with ASD were randomized into two acute 8-week phases in a double-blind placebo-controlled crossover study of liquid fluoxetine. Study design included two randomized 8-week fluoxetine and placebo phases separated by a 4-week washout phase. Outcome measures included measures of repetitive behaviors and global improvement. Low-dose liquid fluoxetine (mean final dose: 9.9+/-4.35 mg/day) was superior to placebo in the treatment of repetitive behaviors by CY-BOCS compulsion scale. The effect size was in the moderate to large range, and the doses used were low. Liquid fluoxetine was only slightly, and not significantly, superior to placebo on CGI autism score partially due to a phase order effect. However, fluoxetine was marginally superior to placebo on a composite measure of global effectiveness. Liquid fluoxetine did not significantly differ from placebo on treatment emergent side effects. Liquid fluoxetine in low doses is more effective than placebo in the treatment of repetitive behaviors in childhood autism. Limitations include small sample size and the crossover design of the study. Further replication and long-term maintenance trials are needed." @default.
• W2007445647 created "2016-06-24" @default.
• W2007445647 creator A5012603245 @default.
• W2007445647 creator A5021935928 @default.
• W2007445647 creator A5023487903 @default.
• W2007445647 creator A5025914671 @default.
• W2007445647 creator A5027292453 @default.
• W2007445647 creator A5075956362 @default.
• W2007445647 creator A5081194822 @default.
• W2007445647 date "2004-12-15" @default.
• W2007445647 modified "2023-10-01" @default.
• W2007445647 title "A Placebo Controlled Crossover Trial of Liquid Fluoxetine on Repetitive Behaviors in Childhood and Adolescent Autism" @default.
• W2007445647 cites W1482645631 @default.
• W2007445647 cites W1488923896 @default.
• W2007445647 cites W1499167392 @default.
• W2007445647 cites W1978189785 @default.
• W2007445647 cites W1985971762 @default.
• W2007445647 cites W2014711343 @default.
• W2007445647 cites W2014893641 @default.
• W2007445647 cites W2018654583 @default.
• W2007445647 cites W2029766096 @default.
• W2007445647 cites W2044657642 @default.
• W2007445647 cites W2050252906 @default.
• W2007445647 cites W2065974729 @default.
• W2007445647 cites W2079773266 @default.
• W2007445647 cites W2110949482 @default.
• W2007445647 cites W2123822033 @default.
• W2007445647 cites W2126866445 @default.
• W2007445647 cites W2129582962 @default.
• W2007445647 cites W2146268699 @default.
• W2007445647 cites W2147341063 @default.
• W2007445647 cites W2149174165 @default.
• W2007445647 cites W2271776958 @default.
• W2007445647 cites W4231413321 @default.
• W2007445647 cites W4237134263 @default.
• W2007445647 doi "https://doi.org/10.1038/sj.npp.1300627" @default.
• W2007445647 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15602505" @default.
• W2007445647 hasPublicationYear "2004" @default.
• W2007445647 type Work @default.
• W2007445647 sameAs 2007445647 @default.
• W2007445647 citedByCount "342" @default.
• W2007445647 countsByYear W20074456472012 @default.
• W2007445647 countsByYear W20074456472013 @default.
• W2007445647 countsByYear W20074456472014 @default.
• W2007445647 countsByYear W20074456472015 @default.
• W2007445647 countsByYear W20074456472016 @default.
• W2007445647 countsByYear W20074456472017 @default.
• W2007445647 countsByYear W20074456472018 @default.
• W2007445647 countsByYear W20074456472019 @default.
• W2007445647 countsByYear W20074456472020 @default.
• W2007445647 countsByYear W20074456472021 @default.
• W2007445647 countsByYear W20074456472022 @default.
• W2007445647 countsByYear W20074456472023 @default.
• W2007445647 crossrefType "journal-article" @default.
• W2007445647 hasAuthorship W2007445647A5012603245 @default.
• W2007445647 hasAuthorship W2007445647A5021935928 @default.
• W2007445647 hasAuthorship W2007445647A5023487903 @default.
• W2007445647 hasAuthorship W2007445647A5025914671 @default.
• W2007445647 hasAuthorship W2007445647A5027292453 @default.
• W2007445647 hasAuthorship W2007445647A5075956362 @default.
• W2007445647 hasAuthorship W2007445647A5081194822 @default.
• W2007445647 hasBestOaLocation W20074456471 @default.
• W2007445647 hasConcept C118552586 @default.
• W2007445647 hasConcept C126322002 @default.
• W2007445647 hasConcept C142724271 @default.
• W2007445647 hasConcept C15744967 @default.
• W2007445647 hasConcept C168563851 @default.
• W2007445647 hasConcept C170493617 @default.
• W2007445647 hasConcept C204787440 @default.
• W2007445647 hasConcept C205778803 @default.
• W2007445647 hasConcept C27081682 @default.
• W2007445647 hasConcept C2775864247 @default.
• W2007445647 hasConcept C2776134451 @default.
• W2007445647 hasConcept C2779177272 @default.
• W2007445647 hasConcept C31487548 @default.
• W2007445647 hasConcept C42219234 @default.
• W2007445647 hasConcept C558461103 @default.
• W2007445647 hasConcept C71924100 @default.
• W2007445647 hasConcept C87813604 @default.
• W2007445647 hasConceptScore W2007445647C118552586 @default.
• W2007445647 hasConceptScore W2007445647C126322002 @default.
• W2007445647 hasConceptScore W2007445647C142724271 @default.
• W2007445647 hasConceptScore W2007445647C15744967 @default.
• W2007445647 hasConceptScore W2007445647C168563851 @default.
• W2007445647 hasConceptScore W2007445647C170493617 @default.
• W2007445647 hasConceptScore W2007445647C204787440 @default.
• W2007445647 hasConceptScore W2007445647C205778803 @default.
• W2007445647 hasConceptScore W2007445647C27081682 @default.
• W2007445647 hasConceptScore W2007445647C2775864247 @default.
• W2007445647 hasConceptScore W2007445647C2776134451 @default.
• W2007445647 hasConceptScore W2007445647C2779177272 @default.
• W2007445647 hasConceptScore W2007445647C31487548 @default.
• W2007445647 hasConceptScore W2007445647C42219234 @default.
• W2007445647 hasConceptScore W2007445647C558461103 @default.
• W2007445647 hasConceptScore W2007445647C71924100 @default.
• W2007445647 hasConceptScore W2007445647C87813604 @default.
• W2007445647 hasIssue "3" @default.
• W2007445647 hasLocation W20074456471 @default.

• next